Pheochromocytoma medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pheochromocytoma}} | {{Pheochromocytoma}} | ||
{{CMG}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
The predominant therapy for pheochromocytoma is surgical resection. Treatment with [[phenoxybenzamine]] followed by [[beta blockers]] is required before surgery. | |||
==Medical Therapy== | ==Medical Therapy== | ||
| Line 15: | Line 16: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
Revision as of 17:34, 2 September 2015
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma medical therapy |
|
Risk calculators and risk factors for Pheochromocytoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The predominant therapy for pheochromocytoma is surgical resection. Treatment with phenoxybenzamine followed by beta blockers is required before surgery.
Medical Therapy
Any surgical option requires prior treatment with both the non-specific alpha adrenoceptor blocker phenoxybenzamine to counteract hypertension and the beta-1 adrenoceptor antagonist atenolol to reduce cardiac output. Given before surgery, these can also block the effect of a sudden release of adrenaline during tumour removal, which would otherwise endanger the anaethetised patient.
Contraindicated medications
Pheochromocytoma is considered an absolute contraindication to the use of the following medications: